AN2 Therapeutics Correlations

ANTX Stock

USD 1.46 0.05 3.55%

The current 90-days correlation between AN2 Therapeutics and Aerovate Therapeutics is 0.14 (i.e., Average diversification). The correlation of AN2 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

AN2 Therapeutics Correlation With Market

Significant diversification

The correlation between AN2 Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.

Moving together with AN2 Stock

0.61

SGHT

Sight Sciences

Pair Corr

Moving against AN2 Stock

0.86	OPT	Opthea	Pair Corr
0.52	FNA	Paragon 28	Pair Corr
0.4	VOR	Vor Biopharma	Pair Corr
0.4	RGEN	Repligen	Pair Corr
0.37	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.35	ELMD	Electromed	Pair Corr
0.63	MASI	Masimo	Pair Corr
0.6	NPCE	Neuropace	Pair Corr
0.5	INGN	Inogen Inc	Pair Corr
0.48	NVRO	Nevro Corp	Pair Corr
0.43	NYXH	Nyxoah	Pair Corr
0.35	INMD	InMode	Pair Corr
0.33	LUCD	Lucid Diagnostics	Pair Corr
0.31	ITGR	Integer Holdings Corp	Pair Corr
0.79	TMCI	Treace Medical Concepts	Pair Corr
0.61	TOI	Oncology Institute Earnings Call This Week	Pair Corr
0.5	HYMTF	Hyundai Motor	Pair Corr
0.36	RKV	Rakovina Therapeutics	Pair Corr
0.33	SWZNF	Schweizerische Nationalbank	Pair Corr

Related Correlations Analysis

	AVTE	ADAG	ACRV	RZLT	ANEB	MLYS	MOLN	PHVS	PEPG	PMVP
AVTE		0.09	0.64	0.47	0.47	0.3	0.25	0.61	0.44	0.47	AVTE
ADAG	0.09		0.07	0.01	-0.49	-0.1	-0.06	-0.3	0.04	-0.08	ADAG
ACRV	0.64	0.07		0.56	0.26	0.02	0.27	0.42	0.17	0.47	ACRV
RZLT	0.47	0.01	0.56		0.16	-0.56	0.43	0.34	-0.29	0.34	RZLT
ANEB	0.47	-0.49	0.26	0.16		0.45	0.02	0.52	0.19	0.25	ANEB
MLYS	0.3	-0.1	0.02	-0.56	0.45		-0.34	0.15	0.54	0.05	MLYS
MOLN	0.25	-0.06	0.27	0.43	0.02	-0.34		0.54	0.3	0.56	MOLN
PHVS	0.61	-0.3	0.42	0.34	0.52	0.15	0.54		0.42	0.68	PHVS
PEPG	0.44	0.04	0.17	-0.29	0.19	0.54	0.3	0.42		0.5	PEPG
PMVP	0.47	-0.08	0.47	0.34	0.25	0.05	0.56	0.68	0.5		PMVP
	AVTE	ADAG	ACRV	RZLT	ANEB	MLYS	MOLN	PHVS	PEPG	PMVP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PMVP	+ 0.68	PHVS
ACRV	+ 0.64	AVTE
PHVS	+ 0.61	AVTE
RZLT	+ 0.56	ACRV
PMVP	+ 0.56	MOLN
PEPG	+ 0.54	MLYS

High negative correlations

MLYS	- 0.56	RZLT
ANEB	- 0.49	ADAG
MOLN	- 0.34	MLYS
PHVS	- 0.3	ADAG
PEPG	- 0.29	RZLT
MLYS	- 0.1	ADAG

Risk-Adjusted Indicators

There is a big difference between AN2 Stock performing well and AN2 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AN2 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AVTE	1.35	0.00	0.00	(0.06)	0.00	0.00	2.07	(3.27)	10.45
ADAG	2.44	(0.17)	0.00	0.28	0.00	0.00	4.04	(5.06)	18.68
ACRV	4.26	(0.01)	0.00	(0.07)	0.00	0.00	10.17	(8.24)	30.57
RZLT	3.05	(0.50)	0.00	(0.70)	0.00	0.00	5.62	(6.49)	22.04
ANEB	5.30	0.81	0.13	0.41	5.26	(7.62)	15.25	(8.77)	40.87
MLYS	4.46	0.68	0.17	(0.50)	4.25	(5.32)	10.04	(8.23)	50.53
MOLN	2.72	(0.28)	0.00	(0.21)	0.00	0.00	7.84	(7.39)	20.58
PHVS	2.21	(0.24)	0.00	3.05	0.00	0.00	5.21	(3.86)	14.29
PEPG	8.31	(0.45)	0.00	(0.22)	0.00	0.00	19.62	(13.91)	92.48
PMVP	1.83	(0.24)	0.00	(0.29)	0.00	0.00	4.41	(3.31)	16.42

AN2 Therapeutics Corporate Management

MBA BS	Chief Officer	Profile
Vince Hernandez	Senior Chemistry	Profile
Eric Easom	CEO, Cofounder	Profile
Michael Alley	CoFounder Biology	Profile
Stephen Prior	Chief Officer	Profile
Paul MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC